JPS6314947B2 - - Google Patents
Info
- Publication number
- JPS6314947B2 JPS6314947B2 JP59248203A JP24820384A JPS6314947B2 JP S6314947 B2 JPS6314947 B2 JP S6314947B2 JP 59248203 A JP59248203 A JP 59248203A JP 24820384 A JP24820384 A JP 24820384A JP S6314947 B2 JPS6314947 B2 JP S6314947B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- csf
- medium
- cell
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 210000004027 cell Anatomy 0.000 claims description 70
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 16
- 210000001519 tissue Anatomy 0.000 claims description 15
- 208000008839 Kidney Neoplasms Diseases 0.000 claims description 11
- 206010038389 Renal cancer Diseases 0.000 claims description 11
- 210000000349 chromosome Anatomy 0.000 claims description 11
- 201000010982 kidney cancer Diseases 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 239000001963 growth medium Substances 0.000 claims description 8
- 230000004663 cell proliferation Effects 0.000 claims description 6
- 238000009826 distribution Methods 0.000 claims description 5
- 239000012091 fetal bovine serum Substances 0.000 claims description 4
- 230000004936 stimulating effect Effects 0.000 claims description 4
- 238000003860 storage Methods 0.000 claims description 3
- 230000005757 colony formation Effects 0.000 claims description 2
- 210000005260 human cell Anatomy 0.000 claims description 2
- 239000002609 medium Substances 0.000 description 21
- 239000012894 fetal calf serum Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 210000002966 serum Anatomy 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 239000012980 RPMI-1640 medium Substances 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 238000012258 culturing Methods 0.000 description 6
- 239000007758 minimum essential medium Substances 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 4
- 210000003714 granulocyte Anatomy 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 210000002540 macrophage Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 210000002798 bone marrow cell Anatomy 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 210000000130 stem cell Anatomy 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- CZWJCQXZZJHHRH-YCRXJPFRSA-N 2-[(1r,2r,3s,4r,5r,6s)-3-(diaminomethylideneamino)-4-[(2r,3r,4r,5s)-3-[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine;sulfuric acid Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O CZWJCQXZZJHHRH-YCRXJPFRSA-N 0.000 description 2
- 201000010000 Agranulocytosis Diseases 0.000 description 2
- 101100008044 Caenorhabditis elegans cut-1 gene Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010018687 Granulocytopenia Diseases 0.000 description 2
- 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 2
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000008260 defense mechanism Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 229960001162 dihydrostreptomycin sulfate Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- -1 disodium salt Chemical class 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 229940056360 penicillin g Drugs 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000003445 Mouth Neoplasms Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 208000026487 Triploidy Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 108010007093 dispase Proteins 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- MKXKFYHWDHIYRV-UHFFFAOYSA-N flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 210000003643 myeloid progenitor cell Anatomy 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 210000001316 polygonal cell Anatomy 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 239000003104 tissue culture media Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59248203A JPS61126030A (ja) | 1984-11-26 | 1984-11-26 | ヒトコロニ−形成刺激因子産生細胞株 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59248203A JPS61126030A (ja) | 1984-11-26 | 1984-11-26 | ヒトコロニ−形成刺激因子産生細胞株 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61126030A JPS61126030A (ja) | 1986-06-13 |
JPS6314947B2 true JPS6314947B2 (fr) | 1988-04-02 |
Family
ID=17174726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59248203A Granted JPS61126030A (ja) | 1984-11-26 | 1984-11-26 | ヒトコロニ−形成刺激因子産生細胞株 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61126030A (fr) |
-
1984
- 1984-11-26 JP JP59248203A patent/JPS61126030A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS61126030A (ja) | 1986-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005302258B2 (en) | Platelets from stem cells | |
JP2001510330A (ja) | MSC―メガカリオサイト前駆体組成物およびメガカリオサイト分離による分離メガカリオサイトと会合するMSC▲下s▼の分離方法 | |
JP3032492B2 (ja) | 骨髄の複製方法 | |
KR20020013480A (ko) | 사람 뇌의 내피세포 및 성장배지 및 원시 cd34+cd38-골수 간세포의 증가방법 | |
US5874307A (en) | Process for induction culture of cytotoxic T lymphocytes having killing activity against tumor cells | |
Lanotte et al. | Collagen gels as a matrix for haemopoiesis | |
AU595813B2 (en) | Process for replicating bone marrow in vitro | |
JP2002543829A (ja) | 哺乳動物造血幹細胞のexvivoでの増殖 | |
CN107864627A (zh) | 包含粘附基质细胞的方法和组合物 | |
WO1998021313A1 (fr) | Procede pour la mise en culture de cellules souches hematopoïetiques | |
JPH08205860A (ja) | 造血細胞の膨大化および移植方法 | |
CN106244545A (zh) | 外泌体在促进造血干/祖细胞增殖中的用途 | |
JPS6314947B2 (fr) | ||
Mandalam et al. | Ex vivo hematopoietic cell expansion for bone marrow transplantation | |
RU2272638C1 (ru) | Биотрансплантат, способ его получения и способ лечения хронического гепатита и цирроза печени (варианты) | |
US6511848B2 (en) | Process for producing and multiplying lymphocytes | |
JP3381224B2 (ja) | リンパ球を生産し、そして増加させる方法 | |
JPS6318470B2 (fr) | ||
JPS6314946B2 (fr) | ||
JPH11180877A (ja) | 巨核球前駆細胞を含む細胞製剤及びその製造方法 | |
JP2002171967A (ja) | 造血細胞群の体外培養方法 | |
EP0498992A2 (fr) | Milieu de culture sans sérveur qui contiènne lysozyme | |
JPS61126031A (ja) | コロニ−形成刺激因子の製造法 | |
KR870001417B1 (ko) | Pta-210 세포주를 이용한 인간 성장호르몬의 생산방법 | |
Koller et al. | Tissue engineering of bone marrow |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |